• 67657 Citations
1972 …2023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

neural networks, functional imaging, dementia, cerebral cortex, cholinergic pathways

Certifications and Licenses

Neurology

Training Experience

1973Internship, Hospital of the University of Pennsylvania
1976Residency, Boston City Hospital
1976Residency, Beth Israel Deaconess Medical Center, Boston
1977Postdoctoral Fellowship, Harvard University

Education/Academic qualification

MD, Harvard Medical School

… → 1972

Research interests

  • Aging
  • Alzheimer's Disease
  • Neurology
  • Neuroscience
  • Psychiatry

Fingerprint Dive into the research topics where Marek-Marsel Mesulam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Primary Progressive Aphasia Medicine & Life Sciences
Alzheimer Disease Medicine & Life Sciences
Brain Medicine & Life Sciences
Cholinergic Agents Medicine & Life Sciences
Language Medicine & Life Sciences
Acetylcholinesterase Medicine & Life Sciences
Temporal Lobe Medicine & Life Sciences
Parietal Lobe Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1997 2023

Publications
Autopsy
Apolipoprotein E4
Aptitude
Gyrus Cinguli
Multimodal Imaging
Frontotemporal Dementia
Alzheimer Disease
Differential Diagnosis
Biomarkers
Neurosciences
Cognition
Education
Executive Function
Motivation
Primary Progressive Aphasia
Language
Research Personnel
Clinical Trials
Dermatoglyphics

Research Output 1972 2019

3 Citations (Scopus)

A blood-based signature of cerebrospinal fluid Aβ 1–42 status

Alzheimer’s Disease Metabolomics Consortium & Alzheimer’s Disease Neuroimaging Initiative, Dec 1 2019, In : Scientific reports. 9, 1, 4163.

Research output: Contribution to journalArticle

Open Access
Cerebrospinal Fluid
Amyloid
Alzheimer Disease
Positron-Emission Tomography
Area Under Curve

Activated microglia in cortical white matter across cognitive aging trajectories

Gefen, T., Kim, G., Bolbolan, K., Geoly, A., Ohm, D., Oboudiyat, C., Shahidehpour, R., Rademaker, A., Weintraub, S., Bigio, E. H., Marsel Mesulam, M., Rogalski, E. & Geula, C., Jan 1 2019, In : Frontiers in Aging Neuroscience. 11, MAY, 094.

Research output: Contribution to journalArticle

Open Access
Microglia
Inflammation Mediators
Gliosis
HLA Antigens
Cognitive Aging
Apathy
Frontotemporal Lobar Degeneration
Dementia
Alzheimer Disease
Frontotemporal Dementia

Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

Alzheimer Disease Genetics Consortium (ADGC), The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE) & Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), Sep 1 2019, In : Nature Genetics. 51, 9, p. 1423-1424 2 p.

Research output: Contribution to journalComment/debate

Open Access
Meta-Analysis
Immunity
Alzheimer Disease
Lipids

Clinical and cortical decline in the aphasic variant of Alzheimer's disease

Rogalski, E., Sridhar, J., Martersteck, A., Rader, B., Cobia, D., Arora, A. K., Fought, A. J., Bigio, E. H., Weintraub, S., Mesulam, M-M. & Rademaker, A. W., Apr 1 2019, In : Alzheimer's and Dementia. 15, 4, p. 543-552 10 p.

Research output: Contribution to journalArticle

Primary Progressive Aphasia
Alzheimer Disease
Language
Amyloid
Atrophy